SP1 and synovial sarcoma: A recently published report on these novel autoantibodies in participants of the DREAM Study demonstrated a higher prevalence of anti-SP1 in patients with SS-related dry eye compared to patients with non-SS dry eye (33% vs. 19%) [14].